Redd&Whyte Appoints New UK Sales Manager Thursday, February 21, 2013 Appointment to provide professional service and support for UK scientists. Joining the Digital Age Thursday, February 21, 2013 TES Pharma has recently purchased an HP D300 Digital Dispenser, and is now reaping the benefits of direct titration with improved assay reproducibility and more time to perform exploratory research. Strem and Codexis Sign Enzyme Distribution Agreement Wednesday, February 20, 2013 The agreement grants Strem exclusive distribution rights for the new 100mg CODEX® Screening Kits for Codexis’ popular Transaminase and Ketoreductase enzyme platforms. Vetter Offers Answers for the Future at the Pharma Congress 2013 Tuesday, February 19, 2013 Experts from the CDMO to discuss the challenges and solutions facing the industry. Diamond Sheds Light on Basic Building Blocks of Life Tuesday, February 19, 2013 The UK’s national synchrotron facility, Diamond Light Source, is now the first and only place in Europe where pathogens requiring Containment Level 3 can be analysed at atomic and molecular level using synchrotron light. MicroRNA Molecule May Serve as Biomarker Monday, February 18, 2013 MicroRNA molecule called miR-7 decreased in highly metastatic cancer stem-like cells. Gene Thought to be Linked to Alzheimer's is Marker for Only Mild Impairment Monday, February 18, 2013 Defying the widely held belief that a specific gene is the biggest risk factor for Alzheimer's disease, report says that people with that gene are more likely to develop mild cognitive impairment -- but not Alzheimer's. A Hybrid Structural Approach to Analyze Ligand Binding by the 5-HT4 Receptor Friday, February 15, 2013 This study reveals the potential of hybrid structural methods, including mass spectrometry to probe physiological and functional GPCR-ligand interactions with purified native protein. Insight Genetics Promotes Four Wednesday, February 13, 2013 Molecular diagnostics company builds expertise and depth in research, application and commercial development of companion diagnostics to improve cancer care.
|